Anticorps Monoclonal anti-m7G
m7G Monoclonal Antibody for IHC, Dot Blot, ELISA, Indirect ELISA
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
chemical compound
Applications
IHC, Dot Blot, ELISA, Indirect ELISA
Conjugaison
Non conjugué
CloneNo.
2C3E10
N° de cat : 68302-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
68302-1-PBS cible m7G dans les applications de IHC, Dot Blot, ELISA, Indirect ELISA et montre une réactivité avec des échantillons chemical compound
Réactivité | chemical compound |
Hôte / Isotype | Mouse / IgG2b |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | Peptide |
Nom complet | m7G |
Symbole du gène | |
Identification du gène (NCBI) | |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine A |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
7-Methylguanosine (m7G) is a modified purine nucleoside. It is a methylated version of guanosine and when found in human urine, it may be a biomarker of some types of cancer. In the RNAs, 7-methylguanosine have been used to study and examine the reaction evolving methylguanosine. It also plays a role in mRNA as a blocking group at its 5´-end. The m7G modification actively participates in biological and pathological functions by affecting the metabolism of various RNA molecules, including messenger RNA, ribosomal RNA, microRNA, and transfer RNA. Increasing evidence indicates a critical role for m7G in human disease development, especially cancer, and aberrant m7G levels are closely associated with tumorigenesis and progression via regulation of the expression of multiple oncogenes and tumor suppressor genes.
Protocol for Dot Blot:
https://www.ptglab.com/protocol/68302-1-IgDotBlot.pdf